Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell culture

14 Apr 2024

Abstract excerpt

BACKGROUND AND PURPOSE: There is a need for effective anti-COVID-19 treatments, mainly for individuals at risk of severe disease such as the elderly and the immunosuppressed. Drug repositioning has proved effective in identifying drugs that can find a new application for the control of coronavirus disease, in particular COVID-19. The purpose of the present study was to find synergistic antiviral combinations for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38616133
DOI: 10.1111/bph.16344

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell culturePMID 38616133Read ↗

Identification of novel antiviral drug combinations in vitro and tracking their developmentSemantic proximity Read ↗

Clinical evidence of the effectiveness of remdesivir in COVID-19 during periods dominated by Delta and Omicron SARS-CoV-2 variants.Semantic proximity Read ↗

In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2.Semantic proximity Read ↗

Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical geneticsSemantic proximity Read ↗

Simeprevir Potently Suppresses SARS-CoV‑2 Replication and Synergizes with RemdesivirSemantic proximity Read ↗

Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymeraseSemantic proximity Read ↗

Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulationSemantic proximity Read ↗

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitroSemantic proximity Read ↗

Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivirSemantic proximity Read ↗

Simeprevir Potently Suppresses SARS-CoV‑2 Replication\nand Synergizes with RemdesivirSemantic proximity Read ↗

Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin.Semantic proximity Read ↗

A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.